Literature DB >> 8455816

The Flinders sensitive line rats: a genetic animal model of depression.

D H Overstreet1.   

Abstract

The Flinders Sensitive Line (FSL) rat, selectively bred for increased responses to the anticholinesterase DFP, was originally proposed as an animal model of depression because, like depressed humans, it is supersensitive to the behavioral and hormonal effects of cholinergic (muscarinic) agonists. The present review critically examines earlier and recent data collected on FSL rats to assess whether the model has good face, construct and/or predictive validity. With respect to face validity, FSL rats resemble depressed humans, at least superficially, in that they demonstrate: (a) reduced locomotor activity, (b) reduced body weight, (c) increased REM sleep, and (d) cognitive (learning) difficulties. So far, studies designed to assess the presence of anhedonia, a cardinal symptom of melancholic depression, have been inconclusive, but there are trends for the FSL rats to be more anhedonic than their control counterparts, the Flinders Resistant Line (FRL) rats, when exposed to chronic mild stress. Thus, FSL rats fulfill the criterion of face validity. Because FSL rats also are more sensitive to cholinergic agonists and have phase advanced circadian rhythms, they meet the criteria for the cholinergic and circadian rhythm models of depression and, therefore, have good construct validity. A key behavioral symptom exhibited by the FSL rat is demonstration of an exaggerated immobility when exposed to stressors such as foot shock and forced swimming. This behavioral abnormality has been normalized by a number of well-recognized antidepressant drugs such as imipramine and desipramine, as well as newer generation antidepressants with promising clinical effects such as sertraline and rolipram. However, several treatments that have not been routinely used to treat depression (lithium, exposure to bright light, the anticholinesterase DFP) have been ineffective in reversing the exaggerated immobility. Thus, the evidence in the present review indicates that the FSL rat model of depression fulfills the criteria of face, construct, and predictive validities.

Entities:  

Mesh:

Year:  1993        PMID: 8455816     DOI: 10.1016/s0149-7634(05)80230-1

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  74 in total

1.  A prescription to resist proscriptions for murine models of depression.

Authors:  I Lucki
Journal:  Psychopharmacology (Berl)       Date:  2001-01       Impact factor: 4.530

2.  Blunted accumbal dopamine response to cocaine following chronic social stress in female rats: exploring a link between depression and drug abuse.

Authors:  Akiko Shimamoto; Joseph F Debold; Elizabeth N Holly; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2011-06-03       Impact factor: 4.530

3.  Hippocampal α7 nicotinic ACh receptors contribute to modulation of depression-like behaviour in C57BL/6J mice.

Authors:  Yann S Mineur; Tenna N Mose; Sam Blakeman; Marina R Picciotto
Journal:  Br J Pharmacol       Date:  2017-04-08       Impact factor: 8.739

4.  Effects of antidepressants on the performance in the forced swim test of two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions.

Authors:  Giovanna Piras; Osvaldo Giorgi; Maria G Corda
Journal:  Psychopharmacology (Berl)       Date:  2010-06-30       Impact factor: 4.530

Review 5.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

6.  Neuropeptide expression in rats exposed to chronic mild stresses.

Authors:  Valeriy Sergeyev; Serguei Fetissov; Aleksander A Mathé; Patricia A Jimenez; Tamas Bartfai; Patrick Mortas; Laurent Gaudet; Jean-Luc Moreau; Tomas Hökfelt
Journal:  Psychopharmacology (Berl)       Date:  2004-10-30       Impact factor: 4.530

Review 7.  Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence.

Authors:  Terril L Verplaetse; Andrea H Weinberger; Philip H Smith; Kelly P Cosgrove; Yann S Mineur; Marina R Picciotto; Carolyn M Mazure; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-03-11       Impact factor: 4.244

8.  Decoding of dopaminergic mesolimbic activity and depressive behavior.

Authors:  Alexander Friedman; Ilana Deri; Yaakov Friedman; Eliyahu Dremencov; Sophia Goutkin; Elizabeth Kravchinsky; Matti Mintz; Dino Levi; David H Overstreet; Gal Yadid
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

9.  Acute citalopram has different effects on regional 5-HT synthesis in FSL, FRL, and SDP rats: an autoradiographic evaluation.

Authors:  Kazuya Kanemaru; Shu Hasegawa; Kyoko Nishi; Mirko Diksic
Journal:  Brain Res Bull       Date:  2008-07-30       Impact factor: 4.077

10.  Early prediction of the effectiveness of antidepressants: inputs from an animal model.

Authors:  Alexander Friedman; Avia Merenlender; Elad Lax; Mordechay Rosenstein; Nachum Lubin; Gal Yadid
Journal:  J Mol Neurosci       Date:  2009-02-14       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.